Get 25% off on 1st online pharmacy purchase. Use Code: NEW2026

Get 25% off on 1st online pharmacy purchase. Use Code: NEW2026

FAQs

|

1-844-385-MEDS

Dr. Steve Malen, PharmD.

Chief Product Officer at Invictus Pharmacy

Connect on LinkedIn

Biography

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Featured Insight

The future of medicine lies not just in breakthrough discoveries, but in our ability to communicate those discoveries effectively.

News & Updates

Stay in the know with the latest in Healthcare

See More

ChatGPT Genetics

The world of pharmacy is rapidly evolving, with new and growing technology continually shaping its future. One striking example is how the same technology capable

Healthcare, Innovative

ChatGPT Pharmacy

All throughout pharmacy school, the one consistent thing you’ll learn is how long, tedious, and costly the research and development process is for drug development.

Healthcare, Innovative

Health is Business

From the New York Times’s most recent article on Pharmacy Benefit Managers (PBMs), we’ve seen that pharmacies and patients are financially struggling while PBMs are

Healthcare

Pharmacy Benefit Managers

Americans are paying too much for prescription drugs. Every day, patients complain about the cost of medication, and pharmacies are closing due to the all-time

Healthcare

Inject Away the Weight

“Oprah Winfrey is on Ozempic” headlines the news, along with a multitude of other celebrities who have come out to speak about their journey using

Pharmaceuticals

Spraying Away Depression

Treatment-resistant depression (TDR), a subset of Major Depressive Disorder (MDD), is characterized by a lack of response to two first-line therapeutic options even with proper

Pharmaceuticals